UNCY - Unicycive Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

UNCY is currently covered by 2 analysts with an average price target of $-0.11. This is a potential upside of $-5.67 (-101.98%) from yesterday's end of day stock price of $5.56.

Unicycive Therapeutics's activity chart (see below) currently has 17 price targets and 33 ratings on display. The stock rating distribution of UNCY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90.1% with an average time for these price targets to be met of 254 days.

Highest price target for UNCY is $7.5, Lowest price target is $7.5, average price target is $7.5.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 11-Apr-2025. First documented stock forecast 09-Aug-2021.

Best performing analysts who are covering UNCY - Unicycive Therapeutics:

Elemer Piros Jason Mccarthy Bruce Jackson Ed Arce

Currently out of the existing stock ratings of UNCY, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$7.5

$1.03 (15.92%)

$7.5

8 months 9 days ago
(11-Apr-2025)

19/23 (82.61%)

$2.02 (36.86%)

103

Buy

$3

$-3.47 (-53.63%)

$3

1 years 28 days ago
(22-Nov-2024)

7/9 (77.78%)

$-2.3 (-43.40%)

162

Buy

$5

$-1.47 (-22.72%)

$5

2 years 5 months 20 days ago
(30-Jun-2023)

4/4 (100%)

$-7.8 (-60.94%)

192

Buy

$6

$-0.47 (-7.26%)

$3

2 years 9 months 11 days ago
(09-Mar-2023)

2/2 (100%)

$-14.6 (-70.87%)

559

Show more analysts

Please expand the browser size to see the chart

What is UNCY (Unicycive Therapeutics) average time for price targets to be met?

On average it took 254 days on average for the stock forecasts to be realized with a an average price target met ratio 90.1

Which analyst has the current highest performing score on UNCY (Unicycive Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the current lower performing score on UNCY (Unicycive Therapeutics) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on UNCY (Unicycive Therapeutics)?

Elemer Piros has 6 price targets and 6 ratings on UNCY

Which analyst is the currently most bullish on UNCY (Unicycive Therapeutics)?

Ed Arce with highest potential upside - $1.03

Which analyst is the currently most reserved on UNCY (Unicycive Therapeutics)?

Bruce Jackson with lowest potential downside - -$3.47

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?